rs3129882

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_Strong

The NM_019111.5(HLA-DRA):c.83-695G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.553 (AC=84,019) in the gnomAD database across 151,994 control chromosomes, including 23,495 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.561. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.55 ( 23495 hom., cov: 31)

Consequence

HLA-DRA
NM_019111.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.47

Publications

1 publications found
Variant links:
Genes affected
HLA-DRA (HGNC:4947): (major histocompatibility complex, class II, DR alpha) HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. This molecule is expressed on the surface of various antigen presenting cells such as B lymphocytes, dendritic cells, and monocytes/macrophages, and plays a central role in the immune system and response by presenting peptides derived from extracellular proteins, in particular, pathogen-derived peptides to T cells. The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_019111.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -4 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.561 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_019111.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

HLA-DRA NM_019111.5
MANE Select
HGVSc / HGVSpc.83-695G>A
Exon rankIntron 1 of 4
intron
Prot: NP_061984.2

Ensembl Transcripts

HLA-DRA ENST00000395388.7
TSL:6MANE Select
HGVSc / HGVSpc.83-695G>A
Exon rankIntron 1 of 4
intron
Prot: ENSP00000378786.2UniProt: P01903
HLA-DRA ENST00000870696.1
HGVSc / HGVSpc.83-695G>A
Exon rankIntron 1 of 3
intron
Prot: ENSP00000540755.1UniProt: P01903
HLA-DRA ENST00000917299.1
HGVSc / HGVSpc.83-695G>A
Exon rankIntron 1 of 4
intron
Prot: ENSP00000587358.1UniProt: P01903

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.553
AC:83971
Hom:23481
AN:151876
Cov:31
GnomAD4 genome
AF: 0.553
AC:84019
Hom:23495
AN:151994
Cov:31
TOPMed (Bravo)
AF: 0.557
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.565
AC:402298
Hom:114906
AN:712332
Local & regional cohorts 9 sources
ABraOM SABE-WGS-1171
AF: 0.541
AC:1268
Hom:346
AN:2342
Denmark Genome
AF: 0.610
AC:183
AN:300
GenomeAsia100K
AF: 0.425
AC:1484
AN:3476
Korea4K (4,157 Koreans)
AF: 0.521
AC:3768
AN:7232
Qatari Genome
AF: 0.563
AC:99
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.438
AC:53685
Hom:11836
AN:122644
Turkish Variome
AF: 0.445
AC:688
Hom:159
AN:1546
UK10K
AF: 0.612
AC:4630
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.376
AC:3369
Hom:646
AN:8960
Showing 13 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign7.7
BayesDel_noAF
Benign-0.86
CADD
Benign5.4
DANN
Benign0.54
GPN-Star LLR
N/A5.3
GPN-Star score
N/A1.2
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign1.5
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.